Comparison of Clinical and Imaginal Features According to the Pathological Grades of Dysplasia in Branch-Duct Intraductal Papillary Mucinous Neoplasm (BD-IPMN) for Personalized Medicine

<b>Background:</b> In patients with BD-IPMN, surgical indications have been focused on finding malignant lesions (HGD, high-grade dysplasia/IC, invasive carcinoma). The aim of this study was to compare the preoperative factors that distinguish HGD from LGD (low-grade dysplasia) and HGD f...

Full description

Bibliographic Details
Main Authors: Ji Eun Na, Jae Keun Park, Jong Kyun Lee, Joo Kyung Park, Kwang Hyuck Lee, Kyu Taek Lee
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:Journal of Personalized Medicine
Subjects:
Online Access:https://www.mdpi.com/2075-4426/13/1/149
_version_ 1797440090621870080
author Ji Eun Na
Jae Keun Park
Jong Kyun Lee
Joo Kyung Park
Kwang Hyuck Lee
Kyu Taek Lee
author_facet Ji Eun Na
Jae Keun Park
Jong Kyun Lee
Joo Kyung Park
Kwang Hyuck Lee
Kyu Taek Lee
author_sort Ji Eun Na
collection DOAJ
description <b>Background:</b> In patients with BD-IPMN, surgical indications have been focused on finding malignant lesions (HGD, high-grade dysplasia/IC, invasive carcinoma). The aim of this study was to compare the preoperative factors that distinguish HGD from LGD (low-grade dysplasia) and HGD from IC to find the optimal pathologic target for surgery according to individuals, considering surgical risks and outcomes. <b>Methods:</b> We retrospectively analyzed 232 patients with BD-IPMN diagnosed based on pathology after surgery and preoperative images. The primary outcome was identifying preoperative factors distinguishing HGD from LGD, and HGD from IC. <b>Results:</b> In patients with LGD/HGD, a solid component or an enhancing mural nodule ≥ 5 mm (OR = 9.29; 95% CI: 3.3–54.12; <i>p</i> < 0.000) and thickened/enhancing cyst walls (OR = 6.95; 95% CI: 1.68–33.13; <i>p</i> = 0.008) were associated with HGD. In patients with malignant lesions (HGD/IC), increased serum CA 19-9 (OR = 12.59; 95% CI: 1.81–87.44; <i>p</i> = 0.006) was associated with IC. <b>Conclusions</b>: The predictive factors for HGD were the presence of a solid component or an enhancing mural nodule ≥ 5 mm and thickened/enhancing cyst walls compared with LGD, and if accompanied by increased CA 19-9, it might be necessary to urgently evaluate the lesion due to the possibility of progression to IC. Based on this finding, we need to find HGD as the optimal pathologic target for surgery to improve survival in low-surgical-risk patients, and IC could be assumed to be the optimal pathologic target for surgery in high-surgical-risk patients because of high morbidity and mortality associated with surgery.
first_indexed 2024-03-09T12:02:06Z
format Article
id doaj.art-d42d9d0fa8be4293a6b083d628040caa
institution Directory Open Access Journal
issn 2075-4426
language English
last_indexed 2024-03-09T12:02:06Z
publishDate 2023-01-01
publisher MDPI AG
record_format Article
series Journal of Personalized Medicine
spelling doaj.art-d42d9d0fa8be4293a6b083d628040caa2023-11-30T23:02:48ZengMDPI AGJournal of Personalized Medicine2075-44262023-01-0113114910.3390/jpm13010149Comparison of Clinical and Imaginal Features According to the Pathological Grades of Dysplasia in Branch-Duct Intraductal Papillary Mucinous Neoplasm (BD-IPMN) for Personalized MedicineJi Eun Na0Jae Keun Park1Jong Kyun Lee2Joo Kyung Park3Kwang Hyuck Lee4Kyu Taek Lee5Department of Medicine, Inje University Haeundae Paik Hospital, Busan 48108, Republic of KoreaDepartment of Internal Medicine, Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul 07441, Republic of KoreaDepartment of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of KoreaDepartment of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of KoreaDepartment of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of KoreaDepartment of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of Korea<b>Background:</b> In patients with BD-IPMN, surgical indications have been focused on finding malignant lesions (HGD, high-grade dysplasia/IC, invasive carcinoma). The aim of this study was to compare the preoperative factors that distinguish HGD from LGD (low-grade dysplasia) and HGD from IC to find the optimal pathologic target for surgery according to individuals, considering surgical risks and outcomes. <b>Methods:</b> We retrospectively analyzed 232 patients with BD-IPMN diagnosed based on pathology after surgery and preoperative images. The primary outcome was identifying preoperative factors distinguishing HGD from LGD, and HGD from IC. <b>Results:</b> In patients with LGD/HGD, a solid component or an enhancing mural nodule ≥ 5 mm (OR = 9.29; 95% CI: 3.3–54.12; <i>p</i> < 0.000) and thickened/enhancing cyst walls (OR = 6.95; 95% CI: 1.68–33.13; <i>p</i> = 0.008) were associated with HGD. In patients with malignant lesions (HGD/IC), increased serum CA 19-9 (OR = 12.59; 95% CI: 1.81–87.44; <i>p</i> = 0.006) was associated with IC. <b>Conclusions</b>: The predictive factors for HGD were the presence of a solid component or an enhancing mural nodule ≥ 5 mm and thickened/enhancing cyst walls compared with LGD, and if accompanied by increased CA 19-9, it might be necessary to urgently evaluate the lesion due to the possibility of progression to IC. Based on this finding, we need to find HGD as the optimal pathologic target for surgery to improve survival in low-surgical-risk patients, and IC could be assumed to be the optimal pathologic target for surgery in high-surgical-risk patients because of high morbidity and mortality associated with surgery.https://www.mdpi.com/2075-4426/13/1/149optimal pathologic target for surgeryBD-IPMNlow-grade dysplasiahigh-grade dysplasiainvasive carcinoma
spellingShingle Ji Eun Na
Jae Keun Park
Jong Kyun Lee
Joo Kyung Park
Kwang Hyuck Lee
Kyu Taek Lee
Comparison of Clinical and Imaginal Features According to the Pathological Grades of Dysplasia in Branch-Duct Intraductal Papillary Mucinous Neoplasm (BD-IPMN) for Personalized Medicine
Journal of Personalized Medicine
optimal pathologic target for surgery
BD-IPMN
low-grade dysplasia
high-grade dysplasia
invasive carcinoma
title Comparison of Clinical and Imaginal Features According to the Pathological Grades of Dysplasia in Branch-Duct Intraductal Papillary Mucinous Neoplasm (BD-IPMN) for Personalized Medicine
title_full Comparison of Clinical and Imaginal Features According to the Pathological Grades of Dysplasia in Branch-Duct Intraductal Papillary Mucinous Neoplasm (BD-IPMN) for Personalized Medicine
title_fullStr Comparison of Clinical and Imaginal Features According to the Pathological Grades of Dysplasia in Branch-Duct Intraductal Papillary Mucinous Neoplasm (BD-IPMN) for Personalized Medicine
title_full_unstemmed Comparison of Clinical and Imaginal Features According to the Pathological Grades of Dysplasia in Branch-Duct Intraductal Papillary Mucinous Neoplasm (BD-IPMN) for Personalized Medicine
title_short Comparison of Clinical and Imaginal Features According to the Pathological Grades of Dysplasia in Branch-Duct Intraductal Papillary Mucinous Neoplasm (BD-IPMN) for Personalized Medicine
title_sort comparison of clinical and imaginal features according to the pathological grades of dysplasia in branch duct intraductal papillary mucinous neoplasm bd ipmn for personalized medicine
topic optimal pathologic target for surgery
BD-IPMN
low-grade dysplasia
high-grade dysplasia
invasive carcinoma
url https://www.mdpi.com/2075-4426/13/1/149
work_keys_str_mv AT jieunna comparisonofclinicalandimaginalfeaturesaccordingtothepathologicalgradesofdysplasiainbranchductintraductalpapillarymucinousneoplasmbdipmnforpersonalizedmedicine
AT jaekeunpark comparisonofclinicalandimaginalfeaturesaccordingtothepathologicalgradesofdysplasiainbranchductintraductalpapillarymucinousneoplasmbdipmnforpersonalizedmedicine
AT jongkyunlee comparisonofclinicalandimaginalfeaturesaccordingtothepathologicalgradesofdysplasiainbranchductintraductalpapillarymucinousneoplasmbdipmnforpersonalizedmedicine
AT jookyungpark comparisonofclinicalandimaginalfeaturesaccordingtothepathologicalgradesofdysplasiainbranchductintraductalpapillarymucinousneoplasmbdipmnforpersonalizedmedicine
AT kwanghyucklee comparisonofclinicalandimaginalfeaturesaccordingtothepathologicalgradesofdysplasiainbranchductintraductalpapillarymucinousneoplasmbdipmnforpersonalizedmedicine
AT kyutaeklee comparisonofclinicalandimaginalfeaturesaccordingtothepathologicalgradesofdysplasiainbranchductintraductalpapillarymucinousneoplasmbdipmnforpersonalizedmedicine